Libo Yang
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Inorganic Chemistry top 10%
- Metal-Organic Frameworks: Synthesis and Applications
Papers in
-
- Breast Cancer Treatment Studies 9
-
- Metal-Organic Frameworks: Synthesis and Applications 9
- Co-authors
- Hong Bu (22 shared papers)Yan Qiu (5 shared papers)Ai‐Xin Zhu (9 shared papers)Quan‐Qing Xu (6 shared papers)Ru Yan (5 shared papers)Zhang Zhang (8 shared papers)Shaobin Jia (5 shared papers)Bing Wei (10 shared papers)
- Journals
- CrystEngComm (4 papers)PLoS ONE (4 papers)Breast Cancer Research and Treatment (3 papers)Organic Chemistry Frontiers (2 papers)The Breast (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Libo Yang
65 papers receiving 965 citations
Libo Yang's Hit Papers
Peers
Comparison fields: 5 of 105
- Cancer Research 188
- Inorganic Chemistry 111
- Oncology 195
- Molecular Biology 287
- Pulmonary and Respiratory Medicine 97
Countries citing papers authored by Libo Yang
This map shows the geographic impact of Libo Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Yang more than expected).
Fields of papers citing papers by Libo Yang
This network shows the impact of papers produced by Libo Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Yang. The network helps show where Libo Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Libo Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 50 | |
| 2 | 2024 | 45 | |
| 3 | 2020 | 37 | |
| 4 | 2020 | 35 | |
| 5 | 2018 | 34 | |
| 6 | 2021 | 34 | |
| 7 | 2015 | 31 | |
| 8 | Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation Hit paper breakdown → | 2025 | 30 |
| 9 | 2021 | 29 | |
| 10 | 2023 | 29 | |
| 11 | 2016 | 28 | |
| 12 | 2022 | 27 | |
| 13 | 2017 | 27 | |
| 14 | 2018 | 26 | |
| 15 | 2015 | 26 | |
| 16 | 2019 | 26 | |
| 17 | 2019 | 26 | |
| 18 | 2013 | 25 | |
| 19 | 2018 | 25 | |
| 20 | 2018 | 24 |
About Libo Yang
Libo Yang is a scholar working on Cancer Research, Inorganic Chemistry, Oncology, Materials Chemistry and Electronic, Optical and Magnetic Materials, having authored 68 papers that have together received 980 indexed citations. Recurring topics across this work include Metal-Organic Frameworks: Synthesis and Applications (9 papers), Breast Cancer Treatment Studies (9 papers), HER2/EGFR in Cancer Research (7 papers), Magnetism in coordination complexes (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Polyoxometalates: Synthesis and Applications (3 papers) and Lanthanide and Transition Metal Complexes (3 papers). The work is most often cited by research in Cancer Research (188 citations), Inorganic Chemistry (111 citations), Oncology (195 citations), Molecular Biology (287 citations) and Pulmonary and Respiratory Medicine (97 citations). Libo Yang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hong Bu, Yan Qiu, Ai‐Xin Zhu, Quan‐Qing Xu, Ru Yan, Zhang Zhang, Shaobin Jia, Bing Wei, Feng Ye and Tianjie Pu. Their work appears in journals such as CrystEngComm, PLoS ONE, Breast Cancer Research and Treatment, Organic Chemistry Frontiers and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.